d pbs (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
99
Structured Review
Thermo Fisher
d pbs
D Pbs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+d+pbs/Phosphate-buffered+saline+(DPBS%2C+1X)%2C+Dulbecco's+formula%2C+without+calcium%2C+without+magnesium/us12595286-775-10-23
Average 99 stars, based on 1 article reviews
D Pbs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+d+pbs/Phosphate-buffered+saline+(DPBS%2C+1X)%2C+Dulbecco's+formula%2C+without+calcium%2C+without+magnesium/us12595286-775-10-23
Average 99 stars, based on 1 article reviews
d pbs - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Control:Article Title: Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Article Snippet: Androgen-independent prostate cancers, correlated with heightened aggressiveness and poor prognosis, are caused by mutations or deletions in the androgen receptor (AR) or the expression of truncated variants of AR that are constitutively activated.. Currently, drugs and drug candidates against AR target the steroid-binding domain to antagonize or degrade AR.. However, these compounds cannot therapeutically access largely intrinsically disordered truncated splice variants of AR, such as AR-V7, which only possess the N-terminal transactivation domain and DNAbinding domain and are missing the ligand-binding domain. Sonication:Article Title: Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Article Snippet: Androgen-independent prostate cancers, correlated with heightened aggressiveness and poor prognosis, are caused by mutations or deletions in the androgen receptor (AR) or the expression of truncated variants of AR that are constitutively activated.. Currently, drugs and drug candidates against AR target the steroid-binding domain to antagonize or degrade AR.. However, these compounds cannot therapeutically access largely intrinsically disordered truncated splice variants of AR, such as AR-V7, which only possess the N-terminal transactivation domain and DNAbinding domain and are missing the ligand-binding domain. Protease Inhibitor:Article Title: Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Article Snippet: Androgen-independent prostate cancers, correlated with heightened aggressiveness and poor prognosis, are caused by mutations or deletions in the androgen receptor (AR) or the expression of truncated variants of AR that are constitutively activated.. Currently, drugs and drug candidates against AR target the steroid-binding domain to antagonize or degrade AR.. However, these compounds cannot therapeutically access largely intrinsically disordered truncated splice variants of AR, such as AR-V7, which only possess the N-terminal transactivation domain and DNAbinding domain and are missing the ligand-binding domain. Article Title: Distinct alpha-synuclein strains derived from Parkinson’s disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model Article Snippet: .. Both tissues were then homogenized at 1:10 (w/v) in the homogenization buffer containing Purification:Article Title: Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Article Snippet: Androgen-independent prostate cancers, correlated with heightened aggressiveness and poor prognosis, are caused by mutations or deletions in the androgen receptor (AR) or the expression of truncated variants of AR that are constitutively activated.. Currently, drugs and drug candidates against AR target the steroid-binding domain to antagonize or degrade AR.. However, these compounds cannot therapeutically access largely intrinsically disordered truncated splice variants of AR, such as AR-V7, which only possess the N-terminal transactivation domain and DNAbinding domain and are missing the ligand-binding domain. Incubation:Article Title: Delivery of Pleckstrin-Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis. Article Snippet: Spheroids were subsequently incubated with primary antibodies against Myc-tag (mouse monoclonal antibody 9E10; Abcam, Waltham, MA; ab32) and MMP-2 (goat polyclonal antibody I34C660; R&D systems, Minneapolis, MN; AF902) in 1% FBS, 1% BSA, and 0.2% TritonX-100 in 1X D-PBS overnight at 4◦C. .. Following extensive washes in Homogenization:Article Title: Distinct alpha-synuclein strains derived from Parkinson’s disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model Article Snippet: .. Both tissues were then homogenized at 1:10 (w/v) in the homogenization buffer containing Cytometry:Article Title: Unexpected intron plasticity and trans-splicing capability suggest spliceosome diversification in the evolutionarily divergent protozoan parasite Trichomonas vaginalis. Article Snippet: Finally, where indicated, RTPCR products were purified from gels (GeneJET Gel Extraction Kit; Thermo Fisher Scientific) and Sanger-sequenced at Auckland Genomics (https://www.genomics.auckland.ac.nz/). .. 2.3.Flow cytometry and microscopy One and a half millilitres of overnight cell cultures of T. vaginalis (0.5-1.0 x 106 cells/ml) were collected and washed twice with 0.2 mL of Microscopy:Article Title: Unexpected intron plasticity and trans-splicing capability suggest spliceosome diversification in the evolutionarily divergent protozoan parasite Trichomonas vaginalis. Article Snippet: Finally, where indicated, RTPCR products were purified from gels (GeneJET Gel Extraction Kit; Thermo Fisher Scientific) and Sanger-sequenced at Auckland Genomics (https://www.genomics.auckland.ac.nz/). .. 2.3.Flow cytometry and microscopy One and a half millilitres of overnight cell cultures of T. vaginalis (0.5-1.0 x 106 cells/ml) were collected and washed twice with 0.2 mL of Centrifugation:Article Title: Unexpected intron plasticity and trans-splicing capability suggest spliceosome diversification in the evolutionarily divergent protozoan parasite Trichomonas vaginalis. Article Snippet: Finally, where indicated, RTPCR products were purified from gels (GeneJET Gel Extraction Kit; Thermo Fisher Scientific) and Sanger-sequenced at Auckland Genomics (https://www.genomics.auckland.ac.nz/). .. 2.3.Flow cytometry and microscopy One and a half millilitres of overnight cell cultures of T. vaginalis (0.5-1.0 x 106 cells/ml) were collected and washed twice with 0.2 mL of Fluorescence:Article Title: Unexpected intron plasticity and trans-splicing capability suggest spliceosome diversification in the evolutionarily divergent protozoan parasite Trichomonas vaginalis. Article Snippet: Finally, where indicated, RTPCR products were purified from gels (GeneJET Gel Extraction Kit; Thermo Fisher Scientific) and Sanger-sequenced at Auckland Genomics (https://www.genomics.auckland.ac.nz/). .. 2.3.Flow cytometry and microscopy One and a half millilitres of overnight cell cultures of T. vaginalis (0.5-1.0 x 106 cells/ml) were collected and washed twice with 0.2 mL of FACS:Article Title: Unexpected intron plasticity and trans-splicing capability suggest spliceosome diversification in the evolutionarily divergent protozoan parasite Trichomonas vaginalis. Article Snippet: Finally, where indicated, RTPCR products were purified from gels (GeneJET Gel Extraction Kit; Thermo Fisher Scientific) and Sanger-sequenced at Auckland Genomics (https://www.genomics.auckland.ac.nz/). .. 2.3.Flow cytometry and microscopy One and a half millilitres of overnight cell cultures of T. vaginalis (0.5-1.0 x 106 cells/ml) were collected and washed twice with 0.2 mL of Radio Immunoprecipitation:Article Title: Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells. Article Snippet: Androgen-independent prostate cancers, correlated with heightened aggressiveness and poor prognosis, are caused by mutations or deletions in the androgen receptor (AR) or the expression of truncated variants of AR that are constitutively activated.. Currently, drugs and drug candidates against AR target the steroid-binding domain to antagonize or degrade AR.. However, these compounds cannot therapeutically access largely intrinsically disordered truncated splice variants of AR, such as AR-V7, which only possess the N-terminal transactivation domain and DNAbinding domain and are missing the ligand-binding domain. Blocking Assay:Article Title: PROS1 released by lung basal cells limits inflammation in epithelial and monocytes during SARS-CoV-2 infection. Article Snippet: .. Blocking buffer comprised of 1% BSA in |